LR Health & Beauty reported its financial results for 2024. Sales increased to $327.9 million in 2024, representing a year-over-year boost of 4.6%. This increase was driven primarily by the realignment of the career plan and successful launches of the company’s cosmetics line and intestinal metabolism treatment.
LR Health & Beauty SE announced its financial results for the fourth quarter and full year 2024. Fourth quarter sales increased by 8% year-over-year to $80 million with an EBITDA of $8.7 million.
LR Health & Beauty honored its company legacy and history as it celebrated its 40th anniversary. The company reflected on its product and sales innovations in 2024, including its LR Health Mission and LR ZEITGARD Signature, as important foundations for future growth.
LR Health & Beauty reported a 7.2% increase in sales in Q3 2024. Total revenue in the quarter reached $73.32 million in sales. The company attributed this revenue boost primarily to the high demand for its new decorative cosmetics line LR ZEITGARD Signature and a large influx of new sales partners as a result of the realignment of its career plan.
LR Health & Beauty SE announced its financial results for the third quarter of 2024. Sales during the quarter increased by 7.2% to $73.2 million. EBITDA during the quarter increased to $7.7 million.
For 15 years, LR Health & Beauty has served kids in need through its philanthropic arm LR Global Kids Fund. The association was founded by the company’s employees and management as a way to help socially disadvantaged children while providing the opportunity for a “self-determined life.” Today, the charity supports 20 projects around the world, […]
LR Health & Beauty SE announced its financial results for the second quarter of 2024, reporting sales of $78 million, a 2.6% increase from the previous year’s quarter. With these results, the company achieved $158 million in sales for the first half of the year, citing its new product launches, including the LR Health Mission and the LR Body Mission, as significant contributors to its positive sales performance.
LR Health & Beauty announced the expansion of its IT landscape with a new near-shore IT hub in Athens. This new hub is part of the company’s larger business strategy that aims to develop and operate most business applications internally and will develop customized solutions for the company’s sales partners.
LR Health & Beauty SE announced its financial results for the first quarter of 2024, reporting revenue of $78.5 million with a normalized EBITDA of $8.4 million. In spite of unfavorable currency effects, the company achieved a 0.8% year-over-year increase in sales.
LR Health & Beauty SE announced its financial results for the full year 2023, reporting a 3% year-over-year increase in revenue to reach $295 million.
LR Health & Beauty SE shareholder Quadriga Capital announced it has won private equity firm Evoco as a major investor in the company. This capital infusion will provide more financial backing that will allow the company to continue driving toward its strategic initiatives.
LR Global Holding GmbH, the parent company of direct selling organization LR Health & Beauty, announced third quarter 2023 sales of $70 million, a slight decrease (0.6%) from the same period in 2022. Sales for the first nine months of the year reached $222.8 million, representing a 4.6% growth rate compared to the first nine months of 2022.